Clinical
RSSArticles
-
Antibiotics and Adverse Events: Doctors, Do No Harm!
A retrospective study found that among 1,488 hospitalized patients who received an antibiotic, 298 (20%) experienced at least one antibiotic-associated adverse drug event.
-
Statin Use Is Associated With a Lower Risk of Community-acquired Staphylococcus aureus Bacteremia
A population-based case-control study from Denmark found the use of statins was associated with a decreased risk for community-associated Staphylococcus aureus bacteremia, with the greatest benefit from higher doses.
-
Lyme Disease in the United States — Good News, Bad News
The incidence of Lyme disease appears to have stabilized in states with known high incidences of the infection, but there is evidence of geographic expansion into neighboring states.
-
Mumps Vaccine — Third Dose During Outbreaks
Mumps immunity wanes over time, with a notable increase in risk of infection 13 or more years after completion of the currently recommended series of vaccines. During an outbreak of mumps, receipt of an extra (third, by American schedules) vaccine significantly reduces the risk of becoming sick with mumps.
-
Optimizing Outcomes for Invasive Treatment of Long-standing, Persistent Atrial Fibrillation
In patients with long-standing, persistent atrial fibrillation, outcomes with an electrophysiologically guided thoracoscopic surgical ablation procedure were superior to a standard catheter approach.
-
Cardiac Magnetic Resonance Identifies High-risk Patients With Acute Myocarditis and Preserved Ejection Fraction
In patients with acute myocarditis and preserved left ventricular ejection fraction who underwent cardiac magnetic resonance, the presence of late gadolinium enhancement involving the midwall layer of the anteroseptum was associated with a worse prognosis.
-
Value of Liver Function Tests in Cardiogenic Shock
A prospective, multicentered, observational study of patients admitted with cardiogenic shock showed that a > 20% rise in alanine aminotransferase in the first 24 hours is associated highly and independently with 90-day mortality.
-
Risk of Major Bleeding With Concurrent Medications in Atrial Fibrillation Patients Taking New Oral Anticoagulants
A large nationwide comprehensive clinical database showed that concomitant use of the new oral anticoagulants with amiodarone, fluconazole, rifampin, and phenytoin increases the risk of major bleeding.
-
ORBITA: Learning the Right Lessons From a Sham-controlled Trial of Angioplasty
In this sham-controlled trial of 200 patients with single-vessel coronary artery disease and stable angina, percutaneous coronary intervention did not increase exercise time significantly compared to a placebo procedure.
-
Fluticasone Furoate, Umeclidinium, and Vilanterol Inhalation Powder (Trelegy Ellipta)
Trelegy Ellipta is indicated for the long-term maintenance treatment of patients with COPD, including chronic bronchitis and/or emphysema.